Clarithromycin associated with torsades de pointes

Jpn Circ J. 1999 May;63(5):421-2. doi: 10.1253/jcj.63.421.


Two cases of QT prolongation and torsades de pointes (TdP) are presented. The patients had been taking clarithromycin (400 mg/day) for respiratory disease. Although erythromycin is reportedly associated with TdP, this is the first report of clarithromycin associated with TdP in the absence of other drugs already known to produce QT prolongation.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Clarithromycin / adverse effects*
  • Clarithromycin / therapeutic use
  • Electrocardiography
  • Female
  • Humans
  • Respiratory Tract Diseases / drug therapy
  • Torsades de Pointes / etiology*
  • Torsades de Pointes / physiopathology*


  • Clarithromycin